UY23735A1 - Lentes oftalmicos con agente anti-toxinas - Google Patents

Lentes oftalmicos con agente anti-toxinas

Info

Publication number
UY23735A1
UY23735A1 UY23735A UY23735A UY23735A1 UY 23735 A1 UY23735 A1 UY 23735A1 UY 23735 A UY23735 A UY 23735A UY 23735 A UY23735 A UY 23735A UY 23735 A1 UY23735 A1 UY 23735A1
Authority
UY
Uruguay
Prior art keywords
lens
cornea
eye
ester
keratitis
Prior art date
Application number
UY23735A
Other languages
English (en)
Inventor
G Vanderlaan Douglas
K Brown-Skrobot Susan
L Schultz Clyde
Original Assignee
Johnson & Johnson Vision Products Nc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Vision Products Nc filed Critical Johnson & Johnson Vision Products Nc
Publication of UY23735A1 publication Critical patent/UY23735A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
    • G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
    • G02B1/041—Lenses
    • G02B1/043—Contact lenses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/22—Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Eyeglasses (AREA)
  • Optical Filters (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)

Abstract

En la presente invención se describe un lente oftálmico para colocarse sobre la superficie anterior del ojo. Dicho lente tiene impregnado en el mismo, o tiene como revestimiento sobre la superficie del mismo, un éster de un alcohol alifático polihídrico y un ácido graso, estando presente dicho éster en una cantidad que es efectiva para prevenir o reducir la liberación de toxinas bacterianas cuando dicho lente se expone a dichas toxinas, y siendo dicho éster seleccionado del grupo que consiste de: a) monoésteres de un alcohol alifático polihídrico y un ácido graso que contiene de 8 a 18 átomos de carbono, y en donde dicho monoéster tiene por lo menos un grupo hidroxilo asociado con su residuo de alcohol alifático; b) diésteres de un alcohol alifático polihídrico y un ácido graso que contiene de 8 a 18 átomos de carbono, y en donde dicho diéster tiene por lo menos un grupo hidroxilo asociado con su residuo de alcohol alifático; y c) mezclas de dichos monoésteres y diésteres. Se caracteriza dicho invento porque al ácido graso es ácido láurico y porque el alcohol polihídrico es glicerol. El éster es monolaurato de glicerilo ó una mezcla de monolaurato de glicerilo y dilaurato de glicerilo, tambie´n puede ser monocaprilato de glicerilo, caprato de glicerilo, o una mezcla de ambos; monomiristato de glicerilo, monopalmitato de glicerilo, monoestearato de glicerilo ó monooleato de glicerilo. Dicho lente es un lente de contacto o de vendaje corneal y es un lente de contacto de hidrogel blando.
UY23735A 1993-03-02 1994-03-02 Lentes oftalmicos con agente anti-toxinas UY23735A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/025,018 US5472703A (en) 1993-03-02 1993-03-02 Ophthalmic lens with anti-toxin agent

Publications (1)

Publication Number Publication Date
UY23735A1 true UY23735A1 (es) 1994-06-16

Family

ID=21823602

Family Applications (1)

Application Number Title Priority Date Filing Date
UY23735A UY23735A1 (es) 1993-03-02 1994-03-02 Lentes oftalmicos con agente anti-toxinas

Country Status (25)

Country Link
US (1) US5472703A (es)
EP (1) EP0613694B1 (es)
JP (1) JP3390999B2 (es)
KR (1) KR940021079A (es)
CN (1) CN1099605C (es)
AT (1) ATE171077T1 (es)
AU (1) AU675101B2 (es)
BR (1) BR9400787A (es)
CA (1) CA2116834A1 (es)
CZ (1) CZ46194A3 (es)
DE (1) DE69413271T2 (es)
ES (1) ES2122163T3 (es)
FI (1) FI940976A (es)
GR (1) GR1002257B (es)
GT (1) GT199400014A (es)
HU (1) HU214060B (es)
IL (1) IL108820A (es)
NO (1) NO940707L (es)
NZ (1) NZ260004A (es)
PH (1) PH31000A (es)
RU (1) RU94007090A (es)
SG (1) SG63541A1 (es)
TW (1) TW289094B (es)
UY (1) UY23735A1 (es)
ZA (1) ZA941430B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0733918B1 (en) * 1995-03-24 2003-07-30 Ocular Research of Boston, Inc. Hydrogel lens pre-coated with lipid layer
US5554187A (en) * 1995-08-18 1996-09-10 Rizzo, Iii; Joseph Medication dispensing intra-ocular lens system
SG80568A1 (en) * 1996-03-05 2001-05-22 Johnson & Johnson Vision Prod Contact lens containing a leachable absorbed antibody
US6592814B2 (en) 1998-10-02 2003-07-15 Johnson & Johnson Vision Care, Inc. Biomedical devices with antimicrobial coatings
US20070104798A1 (en) 1999-10-04 2007-05-10 S.K. Pharmaceuticals, Inc. Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide
FR2804868B1 (fr) * 2000-02-15 2003-03-07 Oreal Utilisation de composes permettant de modifier les proprietes physio-chimiques de la peau et/ou des muqueuses en tant qu'agents empechant ou diminuant l'adhesion des micro-organismes sur ces dernieres
FR2804865B1 (fr) * 2000-02-15 2003-11-28 Oreal Utilisation des corps gras particuliers permettant de modifier les proprietes physio-chimiques de la peau et/ou des muqueuses en tant qu'agents empechant ou diminuant l'adhesion des micro-organismes sur ces dernieres
DE60107461T2 (de) * 2000-10-24 2005-05-12 Bausch & Lomb Inc. Verwendung von kationischen polysacchariden zur verhinderung von bakterienansätzen
US7402318B2 (en) 2001-11-14 2008-07-22 Novartis Ag Medical devices having antimicrobial coatings thereon
AU2003222668A1 (en) * 2002-04-25 2003-11-10 Rapidheal, Inc. Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease
US20030203032A1 (en) * 2002-04-25 2003-10-30 Schultz Clyde L. Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease
US7282214B2 (en) * 2002-12-19 2007-10-16 Johnson & Johnson Vision Care, Inc. Biomedical devices with antimicrobial coatings
US20050255144A1 (en) * 2003-04-09 2005-11-17 Directcontact Llc Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases
US20050074497A1 (en) * 2003-04-09 2005-04-07 Schultz Clyde L. Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
US9216106B2 (en) 2003-04-09 2015-12-22 Directcontact Llc Device and method for the delivery of drugs for the treatment of posterior segment disease
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
US8541413B2 (en) * 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
US20080102095A1 (en) * 2006-10-31 2008-05-01 Kent Young Acidic processes to prepare antimicrobial contact lenses
US20100120013A1 (en) * 2008-11-07 2010-05-13 Mb Research Laboratories, Inc. Procedure for long term corneal culture
US8865685B2 (en) 2011-06-30 2014-10-21 Johnson & Johnson Vision Care, Inc. Esters for treatment of ocular inflammatory conditions
US8974055B2 (en) * 2013-03-15 2015-03-10 Johnson & Johnson Vision Care, Inc. Method and apparatus for encapsulating a rigid insert in a contact lens for correcting vision in astigmatic patients
US10816823B2 (en) 2015-05-04 2020-10-27 École Polytechnique Fédérale de Lausanne Ophthalmic contact lens with compressible affinity matrix
CN105410365B (zh) * 2015-12-17 2019-06-11 浙江大学 一种可替代抗生素的饲料添加剂及其应用
KR20210093609A (ko) 2020-01-20 2021-07-28 이원계 승용차의 창을 통해 내부로 유입되는 공기배출시스템
KR20220152722A (ko) 2021-05-10 2022-11-17 이원계 주행 중 승용차의 측면창을 통해 내부로 유입되는 공기배출시스템
KR20240146355A (ko) 2023-03-29 2024-10-08 이원계 승용차의 회전판 배기도어

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485029A (en) * 1984-03-19 1984-11-27 Minnesota Mining And Manufacturing Company Disinfecting method and compositions
US4931279A (en) * 1985-08-16 1990-06-05 Bausch & Lomb Incorporated Sustained release formulation containing an ion-exchange resin
CA1295941C (en) * 1985-08-16 1992-02-18 Rajan Bawa Sustained-release formulation comprising a hydrophobic polymer system
US5208257A (en) * 1986-04-21 1993-05-04 Kabara Jon J Topical antimicrobial pharmaceutical compositions and methods
CA1302280C (en) * 1986-04-21 1992-06-02 Jon Joseph Kabara Topical antimicrobial pharmaceutical compositions and methods
JPH01206312A (ja) * 1988-02-15 1989-08-18 Kao Corp コンタクトレンズ洗浄剤
US4921279A (en) * 1988-08-18 1990-05-01 Ncr Corporation MICR printing technique and apparatus to minimize rejects with correction stickers
ZM1990A1 (en) * 1989-04-27 1991-06-28 Mcneil Ppc Inc Additives to tampons

Also Published As

Publication number Publication date
RU94007090A (ru) 1996-08-20
CN1099605C (zh) 2003-01-22
KR940021079A (ko) 1994-10-17
EP0613694B1 (en) 1998-09-16
CN1101722A (zh) 1995-04-19
ES2122163T3 (es) 1998-12-16
IL108820A (en) 1997-02-18
CA2116834A1 (en) 1994-09-03
SG63541A1 (en) 1999-03-30
GR1002257B (en) 1996-04-23
EP0613694A1 (en) 1994-09-07
BR9400787A (pt) 1994-11-22
CZ46194A3 (en) 1994-10-19
HU214060B (en) 1997-12-29
US5472703A (en) 1995-12-05
PH31000A (en) 1997-12-23
NO940707D0 (no) 1994-03-01
AU675101B2 (en) 1997-01-23
HUT67519A (en) 1995-04-28
GT199400014A (es) 1995-08-23
DE69413271T2 (de) 1999-04-08
AU5649394A (en) 1994-09-08
NO940707L (no) 1994-09-05
ZA941430B (en) 1995-09-01
DE69413271D1 (de) 1998-10-22
NZ260004A (en) 1995-12-21
FI940976A0 (fi) 1994-03-01
IL108820A0 (en) 1994-06-24
HU9400618D0 (en) 1994-05-30
JPH06343686A (ja) 1994-12-20
ATE171077T1 (de) 1998-10-15
JP3390999B2 (ja) 2003-03-31
TW289094B (es) 1996-10-21
FI940976A (fi) 1994-09-03

Similar Documents

Publication Publication Date Title
UY23735A1 (es) Lentes oftalmicos con agente anti-toxinas
ES2146229T3 (es) Lentilla intraocular delgada.
US5428412B1 (en) Method for treating myopia with an aspheric corneal contact lens
ATE213398T1 (de) Diffraktive/refraktive brillen- und intraokulare linsenkombination für altersbedingte makulardegenerierung
ATE180159T1 (de) Künstliche augenlinse mit verminderter randblendung
EP0766970A3 (en) Method and composition for disinfecting contact lenses
PT1044678E (pt) Emulsoes especificas para a glandula lacrimal para aplicacao topica no tecido ocular
DE60031861D1 (de) Mit einer translationszone ausgestattete intraokularlinse
ES2083030T3 (es) Metodo de tratamiento de la inflamacion ocular.
ATE145126T1 (de) Intraokularlinsenset
GB9306424D0 (en) Contact lens designed to accommodate and correct for the effects of presbyopia
ATE114059T1 (de) Progressives brillenglas.
EP0420598A3 (en) Contact lens based on a hydrophilic gel
ES2098572T3 (es) Lente de correccion.
NO171885C (no) Oftalmiske komfortdraape-opploesninger for intraokular anvendelse ved hydrogelkontaktlinser
DE3170210D1 (en) Spectacle glass for the short-sighted
GB2266786B (en) A pair of spectacles with an optical system for treating dyslexia
GB2016736A (en) Contact lens having one or more lugs
FR2697753B3 (fr) Composition ophtalmique destinée au traitement de la sécheresse oculaire, l'entretien des lentilles de contact et à l'utilisation comme excipient de collyres.